MARKET

SRGA

SRGA

RTI Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.470
0.000
0.00%
After Hours: 1.500 +0.03 +2.04% 19:58 06/11 EDT
OPEN
1.500
PREV CLOSE
1.470
HIGH
1.509
LOW
1.450
VOLUME
6.22M
TURNOVER
--
52 WEEK HIGH
3.970
52 WEEK LOW
1.420
MARKET CAP
162.24M
P/E (TTM)
-0.6237
1D
5D
1M
3M
1Y
5Y
Stocks That Hit 52-Week Lows On Thursday
  During the morning session on Thursday, 3 stocks hit new 52-week lows.
Benzinga · 3d ago
BRIEF-Surgalign Holdings, Inc. Announces $50 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
reuters.com · 3d ago
Surgalign Holdings shares dip on $50M registered direct offering priced at-the-market
Surgalign Holdings (SRGA) shares slide 12.5% on offering ~29M common stock and warrants to purchase up to ~29M common stock at $1.725 per share of common stock and related warrant
Seekingalpha · 3d ago
Surgalign Holdings Reports $50M At-The-Market Offering: ~28.99M Share Offering At $1.725/Share
Surgalign Holdings, Inc. (“Surgalign”) (NASDAQ:SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that it has
Benzinga · 3d ago
Surgalign Holdings Insights: Return On Capital Employed
Surgalign Holdings (NASDAQ:SRGA) reported Q1 sales of $23.29 million. Earnings fell to a loss of $14.43 million, resulting in a 87.83% decrease from last quarter. Surgalign Holdings collected $26.19 million in revenue during Q4, but reported earnings showe...
Benzinga · 6d ago
Surgalign announces collaboration with Inteneural Networks
Surgalign Holdings ([[SRGA]] +0.9%) and Inteneural Networks, a developer of innovative artificial intelligence has announced that they have entered into a strategic collaboration agreement.Under the agreement, Surgalign will gain access
Seekingalpha · 6d ago
BRIEF-Surgalign Holdings Announces Collaboration With Inteneural Networks, A Leading Developer Of Artificial Intelligence For Clinical Neurosciences
reuters.com · 6d ago
Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences
Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, and Inteneural Networks Inc., a developer of innovative artificial intelligence (AI) based appl...
GlobeNewswire · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRGA. Analyze the recent business situations of RTI Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRGA stock price target is 4.714 with a high estimate of 8.00 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 162
Institutional Holdings: 62.86M
% Owned: 56.95%
Shares Outstanding: 110.37M
TypeInstitutionsShares
Increased
48
15.87M
New
24
7.33M
Decreased
21
1.57M
Sold Out
14
5.91M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.06%
Key Executives
President/Chief Executive Officer/Director
Michael Nefkens
Chairman/Director
Stuart Simpson
President/Chief Executive Officer/Director
Terry Rich
Chief Financial Officer/Chief Operating Officer
Jonathon Singer
Executive Vice President
Bryan Cornwall
General Counsel/Secretary
Joshua DeRienzis
Executive Vice President
Roger Rose
Other
Scott Durall
Lead Director/Independent Director
Mark Stolper
Secretary
Thomas Rose
Director
Pawel Lewicki
Independent Director
Jeffrey Lightcap
Independent Director
Thomas McEachin
Independent Director
Paul Thomas
Director
Brian Kushner
Independent Director
Nicholas Valeriani
Independent Director
Philip Chapman
Independent Director
Adrian Smith
No Data
About SRGA
RTI Surgical Holdings, Inc. is a surgical implant company. The Company designs, develops, manufactures and distributes biologic, metal and synthetic implants. The Company's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. It operates in one reportable segment composed of lines of business, including spine, sports and international. The Company manufactures metal and synthetic implants and processes donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using its BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes. The Company's implants are distributed directly to hospitals throughout the United States and in over 50 countries worldwide. It also owns augmented reality and artificial intelligence (ARAI) digital surgery platform.

Webull offers kinds of Surgalign Holdings Inc stock information, including NASDAQ:SRGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRGA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRGA stock methods without spending real money on the virtual paper trading platform.